Remarkable response of nivolumab‐refractory lung cancer to salvage chemotherapy

Promising outcomes of salvage chemotherapy after nivolumab therapy have been reported; however, little is known about the detailed clinical and immunologic features in lung cancer patients in whom nivolumab is unsuccessful. We report two cases of nivolumab‐refractory lung cancer, in which chemothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogawara, Daiki, Soda, Hiroshi, Iwasaki, Keisuke, Suyama, Takayuki, Taniguchi, Hirokazu, Fukuda, Yuichi, Mukae, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754301/
https://www.ncbi.nlm.nih.gov/pubmed/29063735
http://dx.doi.org/10.1111/1759-7714.12543

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754301/
https://www.ncbi.nlm.nih.gov/pubmed/29063735
http://dx.doi.org/10.1111/1759-7714.12543

Ejemplares similares